Caxton Associates (New York)’s Autolus Therapeutics AUTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-84,156	Closed	-$180K	–	432
2022 Q3	$180K	Sell	84,156 -5,200	-6%	-$11.1K	0.02%	396
2022 Q2	$253K	Hold	89,356	–	–	0.02%	404
2022 Q1	$373K	Buy	89,356 +28,714	+47%	+$120K	0.03%	296
2021 Q4	$315K	Buy	+60,642	New	+$315K	0.03%	376